GlassScriptPhysician profile
Amanda Bucher Kwan
NPI 1992150817
$3,876.98
in general payments reported to CMS, 2019-2025
37 companies · $579 in 2025
The $579 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $631 · 2023: $1,064 · 2024: $919 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $489.11 | 2021-2023 | Proclaim |
| Enterra Medical, INC. | $375.41 | 2023-2024 | |
| Aroa Biosurgery Incorporated | $309.56 | 2022-2025 | |
| Boston Scientific Corporation | $242.98 | 2021-2023 | |
| Polynovo North America LLC | $198.11 | 2024-2025 | Novosorb Btm |
| Janssen Pharmaceuticals, INC | $197.80 | 2022-2024 | Xarelto |
| Becton, Dickinson and Company | $184.83 | 2023-2024 | Phasix Mesh |
| Abbvie INC. | $175.76 | 2021-2024 | |
| Kerecis Limited | $136.83 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $116.81 | 2023 | Artiss |
| Smith+Nephew, INC. | $111.07 | 2023-2025 | Versajet, Oasis, Acticoat 4" X 4" |
| Tactile Systems Technology INC | $106.26 | 2022 | |
| Integra Lifesciences Corporation | $105.82 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Scientific Affairs, LLC | $100.28 | 2023 | Xarelto |
| Gilead Sciences, INC. | $96.16 | 2024 | Epclusa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $89.28 | 2023 | |
| Mallinckrodt Hospital Products INC. | $88.25 | 2021 | |
| Melinta Therapeutics, LLC | $78.19 | 2023-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Merck Sharp & Dohme LLC | $72.30 | 2024-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Actelion Pharmaceuticals US, INC. | $67.39 | 2025 | Uptravi, Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $66.34 | 2023-2024 | Gattex |
| Jazz Pharmaceuticals INC. | $57.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $49.79 | 2022 | |
| Sanara Medtech INC. | $46.72 | 2024 | Celleraterx |
| Paratek Pharmaceuticals, INC. | $42.28 | 2023-2025 | Nuzyra |
| Biohaven Pharmaceutical Holding Company LTD. | $39.96 | 2022 | |
| Medtronic, INC. | $38.85 | 2022 | |
| Innovation Technologies INC | $27.61 | 2025 | Irrisept |
| Bioventus LLC | $24.99 | 2022 | |
| Lifenet Health | $22.52 | 2024 | Theragenesis Wound Matrix |
| Convatec INC. | $21.42 | 2022 | |
| Atricure, INC. | $18.07 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Shionogi INC | $17.36 | 2023 | Fetroja |
| Stryker Corporation | $16.19 | 2023 | Spy-Phi System |
| Bard Peripheral Vascular, INC. | $16.09 | 2025 | Ultracor Breast Tissue Marker |
| Vertex Pharmaceuticals Incorporated | $15.13 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $14.03 | 2023 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Kwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.